Mitsubishi Tanabe And Hitachi Establish Therapeutic Robot Center In Japan
This article was originally published in PharmAsia News
Japanese medical device makers Hitachi and Shimadzu, mechatronics giant Yaskawa Denki and drug company Mitsubishi Tanabe Pharma July 9 jointly established a medical robot center in Fukuoka. Based inside Kyushu University Hospital, the center will employ advanced technology to develop endoscopic robots able to operate inside the human body. The Japanese government will provide ¥1.2 billion to encourage innovation in therapeutic robot technology. The center also plans to develop devices to conduct remote surgeries and chemical compounds to detect tumors with diameters of 1 millimeter. (Click here for more - Japanese language
You may also be interested in...
Risdiplam’s efficacy across two clinical trials and oral dosing made it a credible threat before its US FDA approval, but its weight-based pricing falls below Biogen’s Spinraza and Novartis’s Zolgensma.
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency guidance to allow sponsors to continue their work, which a former FDA official says is an indication of where the agency is headed post-COVID-19.